What does Medisoma do?

Medisoma is a specialist medical practice in Schilde. Private Limited, started on 19 April 2007, 1 establishment.

What is the address of Medisoma?

The registered office of Medisoma is located at Rodedreef 28, 2970 Schilde.

Is Medisoma still active?

Yes. According to the CBE (30 September 2026) Medisoma is active, legal situation “Normale toestand”, started on 19 April 2007.

Is Medisoma registered on Peppol?

Yes, Medisoma is registered on the Peppol network with ID 0208:0888868012.

What is the enterprise number of Medisoma?

The enterprise number of Medisoma is BE0888868012.

When was Medisoma founded?

Medisoma was founded on 19 April 2007.

Who are the directors of Medisoma?

According to the 2025 annual accounts, the directors of Medisoma are: Jo Vanoorbeek.

Is Medisoma a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 April 2007; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Medisoma make in 2025?

Medisoma posted a profit after taxes of € 142,073 in financial year 2025.

What is the revenue of Medisoma?

As a small company, Medisoma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 267,418.

Medisoma (Private Limited) - Schilde - BE0888868012

Dossier Medisoma, printed on 30 September 2026 from databakkes.be/en/0888868012/medisoma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Medisoma from Schilde, company number BE0888868012, closed financial year 2025 with a result of € 142,073 after tax. For that financial year Medisoma recorded a gross margin of € 267,418 and equity of € 836,094. Compared with financial year 2024, the result moved from € 125,487 to € 142,073. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on November 28, 2025.

What it is worth Growing

€ 836,094

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 142,073

▲ 13% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 90,861

▲ 43% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 140,362 paid out

99 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 59,598

▲ € 51,553 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 73,223

▼ 11% vs 2024

€ 41,623 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Owed to suppliers

€ 17,843

▼ 7% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 27,898

▲ 211% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 313,525 Gross margin 2022: € 313,525 First fiscal year in the series	€ 211,099 Gross margin 2023: € 211,099 ▼ 33% vs 2022 (€ 313,525) Unfavourable step	€ 237,342 Gross margin 2024: € 237,342 ▲ 12% vs 2023 (€ 211,099) Favourable step	€ 267,418 Gross margin 2025: € 267,418 ▲ 13% vs 2024 (€ 237,342) Favourable step	▲ 13%
Profit after taxes	€ 156,334 Profit after taxes 2022: € 156,334 First fiscal year in the series	€ 89,649 Profit after taxes 2023: € 89,649 ▼ 43% vs 2022 (€ 156,334) Unfavourable step	€ 125,487 Profit after taxes 2024: € 125,487 ▲ 40% vs 2023 (€ 89,649) Favourable step	€ 142,073 Profit after taxes 2025: € 142,073 ▲ 13% vs 2024 (€ 125,487) Favourable step	▲ 13%
Equity	€ 760,673 Equity 2022: € 760,673 First fiscal year in the series	€ 799,321 Equity 2023: € 799,321 ▲ 5% vs 2022 (€ 760,673) Favourable step	€ 834,383 Equity 2024: € 834,383 ▲ 4% vs 2023 (€ 799,321) Favourable step	€ 836,094 Equity 2025: € 836,094 Unchanged (€ 834,383) Favourable step
Total debts	€ 239,737 Total debts 2022: € 239,737 First fiscal year in the series	€ 319,884 Total debts 2023: € 319,884 ▲ 33% vs 2022 (€ 239,737) Unfavourable step	€ 136,000 Total debts 2024: € 136,000 ▼ 57% vs 2023 (€ 319,884) Favourable step	€ 147,501 Total debts 2025: € 147,501 ▲ 8% vs 2024 (€ 136,000) Unfavourable step	▲ 8%
Cash	€ 49,663 Cash 2022: € 49,663 First fiscal year in the series	€ 74,088 Cash 2023: € 74,088 ▲ 49% vs 2022 (€ 49,663) Favourable step	€ 63,650 Cash 2024: € 63,650 ▼ 14% vs 2023 (€ 74,088) Unfavourable step	€ 90,861 Cash 2025: € 90,861 ▲ 43% vs 2024 (€ 63,650) Favourable step	▲ 43%
Land & buildings	€ 257,400 Land & buildings 2022: € 257,400 First fiscal year in the series	€ 237,600 Land & buildings 2023: € 237,600 ▼ 8% vs 2022 (€ 257,400) Unchanged	€ 217,800 Land & buildings 2024: € 217,800 ▼ 8% vs 2023 (€ 237,600) Unchanged	€ 198,000 Land & buildings 2025: € 198,000 ▼ 9% vs 2024 (€ 217,800) Unchanged	▼ 9%
Retained profit	€ 692,073 Retained profit 2022: € 692,073 First fiscal year in the series	€ 730,721 Retained profit 2023: € 730,721 ▲ 6% vs 2022 (€ 692,073) Favourable step	€ 765,783 Retained profit 2024: € 765,783 ▲ 5% vs 2023 (€ 730,721) Favourable step	€ 767,494 Retained profit 2025: € 767,494 Unchanged (€ 765,783) Favourable step
Dividend	€ 222,000 Dividend 2022: € 222,000 First fiscal year in the series	€ 51,000 Dividend 2023: € 51,000 ▼ 77% vs 2022 (€ 222,000) Unchanged	€ 90,425 Dividend 2024: € 90,425 ▲ 77% vs 2023 (€ 51,000) Unchanged	€ 140,362 Dividend 2025: € 140,362 ▲ 55% vs 2024 (€ 90,425) Unchanged	▲ 55%
Bank debt	€ 130,674 Bank debt 2022: € 130,674 First fiscal year in the series	€ 97,924 Bank debt 2023: € 97,924 ▼ 25% vs 2022 (€ 130,674) Favourable step	€ 82,117 Bank debt 2024: € 82,117 ▼ 16% vs 2023 (€ 97,924) Favourable step	€ 73,223 Bank debt 2025: € 73,223 ▼ 11% vs 2024 (€ 82,117) Favourable step	▼ 11%
Balance sheet total	€ 1,000,410 Balance sheet total 2022: € 1,000,410 First fiscal year in the series	€ 1,119,205 Balance sheet total 2023: € 1,119,205 ▲ 12% vs 2022 (€ 1,000,410) Unchanged	€ 970,383 Balance sheet total 2024: € 970,383 ▼ 13% vs 2023 (€ 1,119,205) Unchanged	€ 983,595 Balance sheet total 2025: € 983,595 ▲ 1% vs 2024 (€ 970,383) Unchanged	▲ 1%

Key figures of Medisoma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.

What happened to Medisoma?

What happened at Medisoma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Nov 28, 2025 New annual accounts for financial year 2025: profit of € 142,073 (▲ 13% vs 2024). filed late Source: NBB ↗
Apr 19, 2007 Start of the company according to the CBE. KBO
Apr 11, 2007 New establishment in Schilde. KBO

In short

From € 156,334 profit in 2022 to € 142,073 profit in 2025.

Paid € 229,431 in corporate taxes since 2022.

Best year ever: 2022, with € 156,334 profit.

Paid out € 503,787 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Medisoma? We notify you, reason included.

Follow Medisoma

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Jo Vanoorbeek

Medisoma

IMPLUS

Behind Medisoma is Jo Vanoorbeek. Jo Vanoorbeek is also behind IMPLUS.

See the full network in the app

Directors

According to the 2025 annual accounts

Jo Vanoorbeek

Director

Also active at: IMPLUS

Establishments

Establishment units

Physical locations of this company

Registered office

Rodedreef 28

2970 Schilde

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0888.868.012
VAT number: BE 0888.868.012
Registered office: Rodedreef 28, 2970 Schilde
Names & denominations: Medisoma
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 19 April 2007
Peppol: Active · Active since 24 Oct 2024
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗